Background The cost of pregnancy is increasing over time despite the decline in pregnancy rates. Objective To fully elucidate and evaluate the cost drivers of pregnancy in the US for payers, a systematic review was conducted to understand the main cost components and primary factors that contribute to the direct costs of pregnancy, pregnancy-related complications and unintended pregnancy among women of childbearing age (15-44 years). Data Sources We performed electronic searches in the PubMed database from January 2000 to December 2012, and major women's health and pharmacoeconomics conference proceedings from 2011 to 2012. Study Selection The systematic review is comprised of studies that reported pregnancy, pregnancy-related complications, unplanned pregnancy, and pregnancy-induced monetary costs. The review excluded narrative reports, systematic reviews, model-derived cost of pregnancy papers, non-US-based studies, and reports based solely on expert opinions. Study Appraisal and Synthesis Methods Two reviewers independently applied the inclusion criteria and assessed the quality of the data collected. Disagreements between reviewers were resolved by consensus or by arbitration through a third party, with reference to the original sources. We collected information on the study design and outcomes for each included study. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines in designing, performing, and reporting of the systematic review. Results We identified 40 studies from electronic and handsearching methods. We classified studies based on the primary research topic focusing on the overall cost of pregnancy (N = 10), cost of pregnancy-related complications (N = 26), cost of unintended pregnancy (N = 2), cost of planned pregnancy (N = 1), or cost of pregnancy by facilities (N = 1). In the quality assessment, randomized, non-randomized, and retrospective database studies had low to moderate risk of bias. We determined primary cost drivers based on the highest cost reported in each study. The identified cost drivers were inpatient care, pregnancy delivery, multiple births, complicated cesarean sections, high-risk pregnancy, preterm birth, low birth weight, complications due to conditions such as hypertension, diabetes, anemia, and cancer, and in vitro fertilization. In 2008, the overall mean cost per hospital stay for pregnancy-related incidence ranged from $3,306 to $9,234 in 2012 dollars. The mean cost of pregnancy-related complications that led to preterm birth was as high as $326,953 for an infant born at 25 weeks. It is estimated that over 50 % of live births were unintended in the US. The difference in the cost of unintended pregnancy and intended pregnancy was approximately $536 million.
Limitations One limitation of the systematic review was the exclusion of model-based cost studies which were excluded because of the high level of variation and heterogeneity across sources of reported cost. Another limitation of the review is that the cost of pregnancy perspective is restricted to the US. Conclusion Preventing pregnancy-related complications and reducing unintended pregnancies may lower the overall economic burden of pregnancy on the US health care system.
Key Points for Decision Makers
• Published literature shows that complications during pregnancy are associated with increased medical resource utilization which may lead to the rising cost of pregnancy.
• Interventions to manage comorbid conditions during pregnancy may reduce the overall cost of pregnancy (e.g. insulin therapy taken before pregnancy compared with during pregnancy).
• Additional prospective studies are needed to assess potential cost savings of contraceptives for unintended pregnancies.
Introduction
In the US, overall pregnancy rates have declined over the past two decades. In 2008, the pregnancy rate was 105.5 pregnancies per 1,000 women aged 15-44 years-9 % below the 1990 pregnancy rate of 115.8 pregnancies per 1,000 women [1] . The declining trend is observed in teenagers and women aged 20-29 years. Conversely, the declining trend was not observed in women aged 30 years and above in which the pregnancy rate is higher than the pregnancy rate for this group in the year 2000 [1] . Also, unintended pregnancy rates have not declined significantly between 1982 and 2010 [2] . The National Survey of Family Growth reported that multiple factors contributed to the underlying differences in pregnancy rates over the past two decades. Factors include social and behavioral changes in sexual activity, marriage, divorce, and cohabitation, which affect patterns of intercourse, the social and economic context of childbearing, the introduction of contraceptive methods, and in the proportion of women using contraceptive methods [3] . Despite the decline in overall pregnancy rates in the US, pregnancy-related cost continued to rise. Approximately 25 % of hospitalizations were related to pregnancy and childbirth-related conditions [4] , and mother's pregnancy and delivery was ranked as one of the top 20 most expensive conditions treated in US hospitals in 2008 (the total national hospital bill was $55,479 million) [5] . In the past decade, the mean pregnancy-related charge for a live birth has risen from $7,687 in 2002 to over $10,000 in 2010, inflated to 2012 dollars [6] . The pregnancy-related cost was $3,018 in 2012 dollars, which reflected the actual payment made to the hospital. The 2007 Medical Expenditure Panel Survey (MEPS) estimated that pregnancy or birth-related costs were approximately 4 % of US health care expenditures [7] . Another study that analyzed 3 years of MEPS data from 2000 to 2002 reported that the total annual health care expenditures of women with femalespecific conditions were estimated to be over $100 billion, of which $24.5 billion were pregnancy-related [8] . Kjerulff et al. [8] showed that pregnancy was a primary reason why women sought health care services; approximately 8 % of pregnant women who were uninsured were more likely to forgo prenatal care, which may lead to pregnancy-related complications. The Agency for HealthCare Research and Quality (AHRQ) reported that the total expense for live birth in 2010 was approximately $35 billion [9] .
Several factors (e.g. cesarean section, utilization of diagnostic testing, assisted conception/fertility treatments, and pregnancy-related complications) may serve as the primary contributors to the rising cost of pregnancy, but the independent effect and relative importance of each factor has not been fully evaluated. Delivery by cesarean section in the US has risen by 53 % over the past two decades [10] [11] [12] . In 2007, cesarean sections constituted approximately onethird of childbirth deliveries in the US [10] [11] [12] . The rise in cesarean sections is a potential contributor to the rising cost of pregnancy observed in the US. In addition, increases in the utilization of diagnostic tests, pregnancy-related complications, preterm births and multi-fetal pregnancies could also play a role in the rise of pregnancy-related costs.
To fully elucidate and evaluate the drivers of pregnancyrelated expenditures in the US, we aimed to conduct a systematic literature review to address the research question 'in women of childbearing age (15-44 years) , what are the main cost components and primary factors that contribute to the direct costs paid by third party payers for pregnancy, pregnancy-related complications, and unintended pregnancy in the US?' The research question focuses on evaluating the pregnancy-related cost reported in the literature that contributed to the rise in direct costs.
Methods
To examine the primary factors that contribute to pregnancy-related costs, we followed the guidelines provided in the Cochrane Handbook to conduct the systematic literature review [13] .
Search Strategy
We performed a systematic literature review of the PubMed database from January 2000 to December 2012, and major women ' ' '. In addition, handsearching was performed for additional articles from sources of grey literature, such as the Centers for Disease Control-Data and Statistics website and the Cost-Effectiveness Analysis Registry at Tufts University. Handsearching was conducted to identify studies that were not electronically indexed in PubMed, references of narrative reports, existing systematic reviews, and included studies.
Study Selection Criteria
We included studies that reported pregnancy, pregnancyrelated complications, unplanned pregnancy, and monetary costs related to pregnancy in the systematic review. We excluded narrative reports, systematic reviews, non-USbased studies, and model-derived cost-of-pregnancy papers. We also excluded reports based on expert opinions.
Study Selection Process and Data Extraction
Two reviewers independently applied the inclusion criteria and assessed the quality of the data collected. Each reviewer evaluated the relevant data from the eligible studies and the information was entered electronically into an Excel datacollection form with prepared fields. If relevant data were reported only graphically, we estimated the values by physically measuring the charts with a ruler. Disagreements between reviewers were resolved by consensus or by arbitration through a third party, referring to the original sources.
We collected information on the study design and outcomes for each included study. This included the study characteristics (e.g. study objectives, data source, payer's perspective, reported cost or charge unit and cost components), comparison group, pregnancy-related complications, and the pregnancy cost or charge breakdown.
We classified pregnancy studies into one of five groups: overall cost of pregnancy, pregnancy-related complications, unintended pregnancy, planned pregnancy, and facility-related (i.e. baby-friendly vs. non-baby friendly institution) pregnancy costs. We inflated all cost and charge data to 2012 dollars.
Risk of Bias Assessment
We developed a quality assessment form for each type of study design based on the Cochrane Handbook report of low, unclear, and high risk of bias [13] . From studies in which participants were randomized, we assessed biases such as selection, performance, detection, attrition, and reporting using an assessment tool from the Cochrane Handbook [13] . For non-randomized studies, we adapted the Newcastle-Ottawa Scale for non-randomized studies to assess the following biases: selection, attrition, detection, and information [14] . In addition, we assessed whether the authors controlled for confounders in their analysis [14] . For retrospective claims database studies, we adapted the ISPOR checklist for retrospective database studies [15] . Of the 27 questions from this checklist, we selected questions to assess the quality of retrospective studies that used health-related retrospective databases [15] . The form can be found in the electronic supplementary material (ESM).
Data Management and Reporting
We used Endnote version X5 to store the bibliographic citations from the electronic search. For data entry and descriptive analyses, we used Microsoft Excel 2010. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines [16] in designing, performing, and reporting of the systematic review.
3 Results Figure 1 illustrates the flow diagram of the identified studies. We identified 268 articles through PubMed and handsearching of the grey literature and major conference websites. After abstract screening, we excluded 204 articles because they were either narrative report/review articles (N = 27), did not report information on monetary cost of pregnancy (N = 39), were irrelevant to the cost of pregnancy (N = 55), were non-US-based studies (N = 56), or reported model-derived cost (N = 41). The reasons for exclusion were not mutually exclusive (i.e. one study may have multiple reasons for exclusion). In addition, we excluded 24 articles after full-text review because they were either narrative report/review articles (N = 3), non-US-based studies (N = 4), model-derived cost of pregnancy studies (N = 11), or other (N = 6). The six articles in the 'other' category included studies that reported the cost of abortion, overall health care costs, indirect costs related to health expenditure for infertility treatment, or surgical interventions specific to medical procedures. Of the 40 studies that met the criteria for qualitative synthesis, 35 were full-text articles and 5 were abstracts from major women's health and pharmacoeconomics conference proceedings from 2011 to 2012. We classified the studies based on the primary research topic focusing on either the overall cost of pregnancy (N = 10) [4, 7, 8, [17] [18] [19] [20] [21] [22] [23] , cost of pregnancy-related complications (N = 26), cost of unintended pregnancy (N = 2) [24, 25] , cost of planned pregnancy (N = 1) [26] , or cost of pregnancy by facilities (N = 1) [27] . The cost of pregnancy-related complications category was further broken down into studies that looked at either the cost of pre-or post-term birth (N = 19), comorbid conditions (N = 5) [28] [29] [30] [31] [32] , or environmental exposures (N = 2) [33, 34] . Tables 1, 2, 3, 4, 5, 6 and 7 summarize the 40 included studies by type of pregnancy study and study design.
We examined study design and sources of cost data. Study designs included two randomized clinical trials (5 %) [35, 36] , two prospective longitudinal cohort studies (5 %) [26, 37] , 30 retrospective studies [of which three were longitudinal surveys (8 %) [8, 19, 29] , 13 medical claims analysis (33 %) and 15 medical chart reviews (38 %)], as well as five cross-sectional surveys (13 %) [7, 25, 27, 31, 38] . The distribution of the studies by year of publication from 2000 to 2012 was relatively heterogeneous, with the majority of studies published in the years If the article did not explicitly state the year of cost, the latest year from the data or observation period was reported. If this was not available, the year that the article was published was used [4, 8, 19, 38, [45] [46] [47] and 2011 (N = 9, 23 %) [7, 17, 20, 22, [24] [25] [26] [27] 48] . Data for the cost of pregnancy came from multiple sources. Nineteen studies (48 %) incorporated hospital billing data that comprised individual hospital data or cost information from the AHRQ and Healthcare Utilization Project (AHRQ HCUP). Eight studies (20 %) [18, 23-25, 27, 33, 34, 49] used cost data from managed care programs from health maintenance organizations such as Kaiser Permanente or state/federal programs such as Medicaid or Medicare. Five studies (13 %) [39, 44, 45, 47, 50] used cost data from linked state registries, five studies (13 %) [4, 17, 32, 42, 46] used data from medical claims databases, including MarketScan, MedStat, or Paradigm Health, and three (8 %) [7, 8, 19] used data from national surveys.
The distribution of payers' perspectives across studies was heterogeneous as there were several studies reporting multiple perspectives. Three studies were from a federal government perspective (8 %) [7, 29, 38] , three from a state government perspective (8 %) [39, 44, 47] , nine from a commercial payer perspective (23 %) [4, 17, 18, 32, 33, [36, 40, 43] , three from the societal perspective (8 %) [21, 22, 31] , and the perspectives for ten studies were undetermined (25 %) [20, 26, 28, 30, 35, 37, 41, 48, 52, 53] . Nine studies (23 %) [8, 19, 23-25, 27, 34, 45, 50] looked at multiple payers' perspectives. For instance, four studies [24, 25, 27, 34] observed both the national and state perspectives, while Clements et al. [45] and Xu et al. [50] looked at the state and institutional level, and the state and societal level, respectively. Machlin and Rohde [19] included federal, state, commercial and individual perspectives. We determined the primary cost drivers based on the highest cost reported in each study. The identified cost drivers were inpatient care, pregnancy delivery, multiple births, complicated cesarean section, high-risk pregnancy, preterm birth, low birth weight, complications due to conditions such as hypertension, diabetes, anemia, and cancer, and in vitro fertilization. a If the article did not explicitly state the year of cost, the latest year from the data or observation period was reported. If this was not available, the year that the article was published was used
Overall Cost of Pregnancy
Among the ten studies that reported overall cost of pregnancy, high variability in how cost was reported was observed across all studies. For example, cost data for Merrill and Steiner [21] and Podulka et al. [22] came from the same source, the Nationwide Inpatient Sample sponsored by AHRQ, but comparisons could not be made because the metric for reporting cost was different. Merrill and Steiner reported cost as mean hospital charges per delivery (ranging from $8,680 to $22,400 per delivery), while Podulka et al. converted the hospital charges to cost and presented cost as a mean cost per hospital stay (ranging from $3,306 to $9,234 per stay). Conway et al. [7] reported that 69 % of overall cost, estimated at $46 billion in 2007, is due to inpatient care. In Gazmararian et al. [18] , among the reasons for hospitalization and the associated costs for pregnant women, preterm labor made up approximately 19 % of overall hospitalization charges, estimated at $50 million. They also reported the cost associated with pregnancy loss and found that ectopic pregnancy contributed to almost 50 % of the hospitalization charges for pregnancy loss, estimated at $9 million. A medical claims analysis study examined the costs of pregnancy and delivery and prescription contraceptives, including oral contraceptives and intrauterine devices [17] . The cost of pregnancy/delivery per member per month was $15.62 for pregnancy and delivery care, $1.82 for oral contraceptives, and $0.32 for intrauterine devices [17] . Table 8 provides a summary of the overall cost of pregnancy.
Pregnancy-Related Complications
Studies that examined the cost of pregnancy-related complications were categorized as the cost of pre-or post-term birth, comorbid conditions, or environmental exposures. Table 9 provides additional information on the cost or charge breakdown for maternal or neonatal care. Nineteen studies that compared the costs of pre-or post-term birth stratified costs by gestational age or birth weight. For example, Phibbs and Schmitt [43] linked California vital records data with hospital discharge data to examine premature infants between 24 and 37 weeks of gestation.They a If the article did not explicitly state the year of cost, the latest year from the data or observation period was reported. If this was not available, the year that the article was published was used a If the article did not explicitly state the year of cost, the latest year from the data or observation period was reported. If this was not available, the year that the article was published was used [51] , which identified patients using medical records from two hospitals, and Schmitt et al. [44] , which linked California vital statistics with maternal and newborn hospital discharge records to examine the association between premature delivery and birth weight, reported costs by birth weight. Normal birth weight infants had an estimated total health care charge of approximately 50 % ($5,488) less than moderately low birth weight infants (gestational age of 32-36 weeks) after 1-year post-discharge from the hospital [51] . Schmitt et al. [44] reported mean cost per low birth weight infants to be in the range of $12,582 to $309,123 for neonatal care with birth weight from 2000 grams to less than 500 grams. Some studies, such as that by Nicholson et al. [48] , which identified patients from hospital records, compared the cost of labor induction methods with usual care. They reported a total neonatal and maternal mean cost of $17,184 for the Active Management of Risk in Pregnancy at Term (AMOR-IPAT) program and mean cost of $17,901 for usual care.
Five studies provided the cost of pregnancy-related complications related to comorbid conditions. Barton et al. [28] compared the cost of an intervention program for pregnancy-related hypertension and reported the maternal cost to be $6,843 for women who participated in the program and $14,458 for those who did not. Chinthammit et al. [29] reported that the maternal cost of pregnancy was $34,503 among patients with cancer. Gabbe et al. [30] conducted a medical chart review and cross-sectional survey of diabetic mothers after delivery and compared the cost of insulin pump therapy related to complications of type 1 diabetes among women who initiated insulin pump therapy during pregnancy, women who used multiple insulin injections, and women who used insulin pump therapy before pregnancy. They reported that the combined maternal and neonatal cost was $54,677 for mean gestational age at delivery of approximately 36 weeks for type 1 diabetic mothers who initiated insulin pump therapy during pregnancy. Additional comparison of costs for different mean gestational ages and breakdown of costs by maternal or neonatal care across the three groups of diabetic mothers can be found in Table 10 . James et al. [31] used the Nationwide Inpatient Sample and reported the cost for mothers diagnosed with anemia to be $7,487 compared with $5,002 for mothers without anemia. Rein et al. [32] used the National Hospital Discharge Survey and reported $3,524 as the mean unit cost of ectopic pregnancy related to pelvic inflammatory disease; inpatient and outpatient costs were presented as $11,734 and $2,059, respectively.
Two studies reported the cost of environmental exposures related to pregnancy (Table 11) . Goler et al. [33] compared the costs of an intervention program (Early Start) among women who screened positive for substance abuse with women who did not participate in the intervention program. The maternal and neonatal costs ranged from $9,110 to $11,956 across the comparators. Thorsen and Khalil [34] compared the cost of pregnancy for women who smoked and women who did not smoke during pregnancy ($8,828 vs. $6,980 in total costs, respectively). Table 12 provides the costs of unintended pregnancy reported in two studies. Monea and Thomas [24] focused on unintended pregnancies resulting in births, fetal losses, and abortions, as identified through Medicaid and Children's Health Insurance Program databases. The mean costs per live birth, abortion, and fetal loss were $6,395, $111, and $268, respectively. Sonfield et al. [25] examined the proportion of births that resulted from unintended pregnancies for 2006 derived from the Pregnancy Risk Assessment Monitoring System, a population-based surveillance project of the Centers for Disease Control and Prevention, and reported the cost for intended live births and unintended live births. Combined maternal and neonatal costs of care were $13,166 million for intended live births and $13,702 million for unintended live births [25] . We summarized studies that looked at planned pregnancy and, in particular, in vitro treatment and differences in facility-related characteristics. Description and cost information can be found in the ESM (Tables SI-SII) .
Unintended Pregnancy

Quality Assessment of Included Studies
We grouped studies into three categories for quality assessment. We classified two studies as randomized controlled trials, 25 studies as non-randomized studies, and 13 studies as retrospective database studies. Tables 13, 14 and 15 provide the quality assessment for each study.
Among the two randomized controlled trials (Table 13) , there was a moderate to low risk of bias overall. Minimal levels of selection, attrition, and reporting biases were present across the two studies. The presence of performance and detection biases was high because blinding of participants and personnel were not reported. Brooten et al. [36] had a high risk of performance bias and an unclear risk of detection bias. Grobman et al. [35] had high risk of both performance and detection biases.
Non-randomized studies included prospective and retrospective studies and cross-sectional surveys (Table 14) . Overall, the studies described the study eligibility criteria, identified the study population as similar to the target population, had ascertainment of the exposures without the participant's knowledge about the outcomes, and applied methods to control for confounders. Five studies [39, 40, 43, 51, 53] excluded participants from the analysis of the outcome without pre-specification. Differential selection bias was observed in one study [7] in which a difference in the proportion of participants excluded was found for two groups of participants. Two studies [8, 43] did not report how missing data were addressed. Three studies [37, 43, 47] used different protocols for assessing patients during follow-up, which may have introduced detection bias. Approximately 50 % of the non-randomized studies were found to be susceptible to misclassification due to the method of ascertaining the exposure or outcome, which could lead to information bias. Among the 13 retrospective database studies (Table 15) , we observed low to moderate risk of bias for detailed descriptions on the rationale for data source, a priori database analysis plans, descriptions of sample selection, eligibility of participants for the time period in which measurement was assessed, a temporal relationship observed between exposure and outcome, establishment of a link between the natural progression of the disease and the time period of analysis, and methods to control for confounders were applied. Five studies [23, 32, 34, 42, 45] did not take into account differences in coding and reporting across studies. Only three studies [34, 45, 49] had a comparator group and described the identification and characteristics of the comparator in detail. Thorsen and Khalil [34] did not report information on censoring participants during the course of the analysis and did not mention the criteria for establishing the temporal relationship between the identification of a participant with a condition and the outcome of interests. It was often unclear whether the data could differentiate and identify the occurrence of the interventions and outcomes in three studies [32, 42, 45] ; thus, the presence of detection bias was plausible.
Discussion
Overall, we found a high level of heterogeneity among the included studies due to variability in study design, duration of study period, sources of cost data, reporting of cost, absence of a comparator group, and the types of outcomes reported across studies. Study design played a key role in PID pelvic inflammatory disease the source of cost data. For retrospective claims analyses, costs were reported from the perspective of the commercial payer. For retrospective chart reviews linked to registries, estimated costs came from hospital billing data and, in many instances, the cost perspective was not reported. Study design also determined the duration of the study period. In retrospective claims studies, a longer duration of study period was observed compared with prospective studies. The metric for reporting costs varied among individual patient costs, combined maternal and neonatal costs of care, total cost of care, and cost of care broken down to additional subcategories. Differences in the metrics for reporting cost made it challenging to summarize or standardize costs across studies. Furthermore, there was no comparator group for some studies and the types of outcomes observed, and the associated costs related to the outcomes differed across studies. Therefore, direct comparisons of cost across studies could not be assessed.
Reporting of a cost driver is limited to the costs reported within each study. Among studies that looked at pregnancy-related complications, we observed an increase in medical resource utilization compared with no medical complications during pregnancy. Merrill and Steiner [21] and Podulka et al. [22] examined vaginal delivery and cesarean sections with and without complications, respectively. The reported costs in the groups without complication were lower than in the groups with complication by approximately 25 %. Studies that examined preterm labor and low birth weight observed that the cost of pregnancy in the preterm labor and low birth weight groups was approximately ten times higher than in the normal gestational age group of 37 weeks. Another study that compared anemic mothers with non-anemic mothers reported a higher average total hospitalization cost among anemic mothers than non-anemic mothers. Although direct comparisons of pregnancy-related complications could not be made across the included studies, the within-study comparisons provided evidence that complications during pregnancy were correlated with increased medical resource utilization.
Cost of pregnancy-related complications and cesarean section are two factors that contribute to the overall cost of pregnancy in the US. Another factor is unintended pregnancy, which could place an additional cost burden on the US health care system, as illustrated by Sonfield et al. [25] . In light of the limited number of prospective studies examining unintended pregnancy, an economic model examining the burden of unintended pregnancy in the US developed by Trussell et al. [54] further support the findings of Sonfield et al. [25] . This model estimates the direct costs of unintended pregnancy among women who had poor contraceptive adherence. Overall, the model reported that the annual cost of unintended pregnancy was $4.6 billion [54] . Of this, 53 % of the cost could be attributed to women who had poor contraceptive adherence [54] . Under the assumption that a small percentage of women under the age of 30 years switched from oral contraception to long-acting reversible contraception, the authors estimated a reduction in cost of $288 million per year [54] . The limitation of the economic model is that the cost was driven by expected probabilities that were not substantiated by real-world cost data relating to unintended pregnancy.
The limited number of studies that reported on this topic may also be due to the challenge of designing a prospective study that assesses intended and unintended births and contraceptive use simultaneously. A further limitation of the review is the exclusion of model-based cost studies which may provide additional studies on cost. We excluded model-based cost studies because the sources of cost were heterogeneous. Another limitation is the restriction of the cost of pregnancy perspective to the US. In settings where population growth is an issue, family planning and contraceptive methods are widely promoted. Research on the costs of intended and unintended pregnancy in these settings is warranted. Preconception and continuous care and treatment of pregnant women at risk for complications is needed to reduce the cost of care for complication-related events. Additional findings from one study showed that diabetic mothers treated with an insulin pump before pregnancy had a lower mean total cost of care than women who started insulin pump therapy during pregnancy.
Conclusion
Overall, the available evidence suggests that preventing pregnancy-related complications and reducing unintended pregnancies may lower the overall economic burden of pregnancy on the US health care system.
